106 related articles for article (PubMed ID: 16099905)
21. trans-dominant interference with virus infection at two different stages by a mutant envelope protein of Friend murine leukemia virus.
Matano T; Odawara T; Ohshima M; Yoshikura H; Iwamoto A
J Virol; 1993 Apr; 67(4):2026-33. PubMed ID: 8445721
[TBL] [Abstract][Full Text] [Related]
22. Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.
Métais JY; Topp S; Doty RT; Borate B; Nguyen AD; Wolfsberg TG; Abkowitz JL; Dunbar CE
Gene Ther; 2010 Jun; 17(6):799-804. PubMed ID: 20237508
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.
Liu L; Anderson WF; Beart RW; Gordon EM; Hall FL
J Virol; 2000 Jun; 74(11):5320-8. PubMed ID: 10799609
[TBL] [Abstract][Full Text] [Related]
24. Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein.
Baldwin CE; Berkhout B
Retrovirology; 2006 Nov; 3():84. PubMed ID: 17134507
[TBL] [Abstract][Full Text] [Related]
25. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance.
Granowitz C; Colicelli J; Goff SP
Virology; 1991 Aug; 183(2):545-54. PubMed ID: 1853560
[TBL] [Abstract][Full Text] [Related]
26. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
Lavillette D; Boson B; Russell SJ; Cosset FL
J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
[TBL] [Abstract][Full Text] [Related]
27. Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein.
Kuznetsov YG; Low A; Fan H; McPherson A
Virology; 2004 Jun; 323(2):189-96. PubMed ID: 15193915
[TBL] [Abstract][Full Text] [Related]
28. A Moloney murine leukemia virus-based retroviral vector pseudotyped by the insect retroviral gypsy envelope can infect Drosophila cells.
Teysset L; Burns JC; Shike H; Sullivan BL; Bucheton A; Terzian C
J Virol; 1998 Jan; 72(1):853-6. PubMed ID: 9420299
[TBL] [Abstract][Full Text] [Related]
29. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
[TBL] [Abstract][Full Text] [Related]
30. Membrane activity of an amphiphilic alpha-helical membrane-proximal cytoplasmic domain of the MoMuLV envelope glycoprotein.
Epand RF; Zhang YL; Mirzabekov T; Kagan B; Silberstein A; Hubbell WL; Epand RM; Chakraborti S; Dimitrov DS; Anderson WF; Rozenberg-Adler Y
Exp Mol Pathol; 2008 Feb; 84(1):9-17. PubMed ID: 18206141
[TBL] [Abstract][Full Text] [Related]
31. Promotion of retroviral entry in the absence of envelope protein by chlorpromazine.
Taylor GM; Zullo AJ; Larson GM; Sanders DA
Virology; 2003 Nov; 316(1):184-9. PubMed ID: 14599802
[TBL] [Abstract][Full Text] [Related]
32. Effects of the ligand sequence modifications on the retargeted transduction by the retroviral vector having a ligand-chimeric Env protein.
Miyakawa K; Fujita R; Katane M; Kubo Y; Amanuma H
J Gen Virol; 2008 Dec; 89(Pt 12):3137-3143. PubMed ID: 19008403
[TBL] [Abstract][Full Text] [Related]
33. Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins.
Hatziioannou T; Russell SJ; Cosset FL
Virology; 2000 Feb; 267(1):49-57. PubMed ID: 10648182
[TBL] [Abstract][Full Text] [Related]
34. A transient three-plasmid expression system for the production of hepatocytes targeting retroviral vectors.
Qi P; Han J; Lu Y; Wang C; Zhu B
Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):567-74. PubMed ID: 17687491
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
36. Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins.
Li F; Ryu BY; Krueger RL; Heldt SA; Albritton LM
J Virol; 2012 Jan; 86(1):373-81. PubMed ID: 22013043
[TBL] [Abstract][Full Text] [Related]
37. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of the envelope gene of Moloney murine leukemia virus.
Gray KD; Roth MJ
J Virol; 1993 Jun; 67(6):3489-96. PubMed ID: 7684467
[TBL] [Abstract][Full Text] [Related]
39. Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein.
Nakamura H; Takeda A; Matano T
Arch Virol; 2001; 146(5):953-61. PubMed ID: 11448032
[TBL] [Abstract][Full Text] [Related]
40. The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins.
Ryu BY; Zavorotinskaya T; Trentin B; Albritton LM
J Gen Virol; 2008 Apr; 89(Pt 4):1049-1058. PubMed ID: 18343849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
